Organising committee member @ International Workshop on Cardiovascular Biology & Translational Medicine (June 2014 - Present)
Vice President Translational Biology and Fibrosis @ (July 2022 - August 2025)
Senior Director, Fibrosis @ (March 2021 - July 2022)
Director, Patient Based Target ID, Immunology TA @ (December 2019 - March 2021)
Director, Pulmonary Vascular Injury and Fibrosis DPU @ (April 2018 - November 2019)
Associate Director Non-Oncology @ (August 2017 - April 2018)
Drug Discovery Group Leader @ (October 2015 - August 2017)
Associate Professor- Tissue Remodeling Group @ (September 2011 - September 2015)
Group Leader - Respiratory @ (February 2006 - March 2011)
Alan Holmes Education
University College London, U. of London
PhD (Molecular mechanisms that contribute to fibrosis in scleroderma)
2000-2006
University of Leicester
BSc (Biology/Biological Sciences)
1990-1993
Alan Holmes Summary
Alan Holmes, based in London, England, GB, is currently a Senior Vice President, Head of Biology at Khanda Therapeutics. Alan Holmes brings experience from previous roles at Khanda therapeutics, UCL, International Workshop on Cardiovascular Biology & Translational Medicine and Engitix Therapeutics. Alan Holmes holds a 2000 - 2006 PhD in Molecular mechanisms that contribute to fibrosis in scleroderma @ University College London, U. of London. Alan Holmes has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Alan Holmes?
Find contact details for 700 million professionals.